# Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

> **NCT02294253** · PHASE2,PHASE3 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 30 (actual)

## Conditions studied

- Opioid Dependence

## Interventions

- **DRUG:** Buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT02294253
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294253, "Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02294253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*